Ceva Animal Health takes on distribution of FILAVAC

Ceva Animal Health has taken on the exclusive distribution of FILAVAC, the market leading RHDV 1 and 2 (rabbit haemorrhagic disease) vaccine.

The product of choice for the majority of veterinary practices with over 92% market share1, FILAVAC is fully licensed for use in rabbits within the UK and provides 12 months duration of immunity ensuring it easily fits into annual vaccination and healthcare plans. It can be administered from 10 weeks of age with a seven-day onset of immunity and the 5 x 0.5ml single dose presentation provides vets and rabbit owners with cost-effective and convenient vaccination options.

“Rabbits are increasingly popular as household pets and should therefore become an important focus for veterinary practices,” comments Nicki Glen, marketing project manager for FILAVAC at Ceva Animal Health. “We are delighted to have taken on the exclusive distribution of FILAVAC to provide veterinary practices with a competitively priced and convenient vaccination for both RHDV 1 and 2.”

Ceva’s distribution of FILAVAC demonstrates the company’s investment in extending its vaccine range.